Efficacy and safety of extended-release niacin/laropiprant plus statin vs. doubling the dose of statin in patients with primary hypercholesterolaemia or mixed dyslipidaemia

Abstract

Lipid lowering and safety of the treatment with niacin/laropiprant plus statin vs. doubling the dose of statin in patients with primary hypercholesterolaemia and mixed dyslipidaemia

Keywords

• Niacin
• cholesterol
• lipidlowering
• hypercholesterolaemia
• tredaptive